Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
about
In vitro activity of thiamphenicol against multiresistant Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in ItalyA single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.Inspecting the potential physiological and biomedical value of 44 conserved uncharacterised proteins of Streptococcus pneumoniaeVancomycin stress response in a sensitive and a tolerant strain of Streptococcus pneumoniae.Vancomycin tolerance induced by erythromycin but not by loss of vncRS, vex3, or pep27 function in Streptococcus pneumoniae.Current pharmacotherapy of pneumococcal meningitis.Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniaeDevelopment and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests.Determination of vancomycin minimum inhibitory concentration for ceftazidime resistant Streptococcus pneumoniae in IranGarenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.Evolution and spread of antibiotic resistance.Vancomycin-tolerant Streptococcus pneumoniae in KoreaVancomycin resistance: occurrence, mechanisms and strategies to combat it.Protective immunity of pneumococcal glycoconjugates.Antimicrobial resistance in respiratory tract pathogens.Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in children with acute bacterial meningitis in Mozambique: implications for a national immunization strategy.Current concepts in the treatment of bacterial meningitis beyond the neonatal period.Emergence and trends of penicillin non-susceptible Streptococcus pneumoniae in Saudi Arabia and Kuwait - perspective and outstanding issues.A diversity of Antibiotic-resistant Staphylococcus spp. in a Public Transportation System.Intravitreal daptomycin: a safety and efficacy studyInvasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host.Emerging drugs for acute bacterial meningitis.Antibacterial activity of a competence-stimulating peptide in experimental sepsis caused by Streptococcus pneumoniae.Revising the role of the pneumococcal vex-vncRS locus in vancomycin tolerance.Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model.Lack of vancomycin tolerance in Streptococcus pneumoniae strains isolated in Barcelona, Spain, from 1999 to 2001.Vancomycin tolerance in enterococci.Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
P2860
Q28209003-D6A0D866-3A65-4441-9027-6BECC4DD4D86Q33559083-1D755A47-56D1-491E-84F0-29FD8E859013Q34085006-9F2A18C7-3BC0-46A7-A1E2-BA61A2811819Q34151003-2770C90A-8D28-49B1-9ACF-845977AADA51Q34321070-993552EC-B3B7-4FEE-800E-FEA7EB4436C1Q34519236-5B289814-23A3-4627-9641-37A5B70C70E2Q34530684-5C28DF8A-95E5-486E-9947-77622598C18AQ34632848-189B64E7-5E9C-46CD-8A1B-9094427B8ED8Q34667511-0734DC7A-E5E4-4984-A351-F68F78FDC27BQ34719869-D818C495-636A-4FA7-91B6-79A5FFE95EF7Q34792403-F0688969-41BB-4910-9D59-09B742E6EA7DQ35073532-143EAE2D-9F48-4FD2-AA03-FB12FB72803BQ35143886-C8D92990-330D-4B00-B8BB-CB788D7B7997Q35592367-AB6A7FB7-12B4-4829-B6CF-11A423FBA4E4Q35917507-BD6C44D4-8F68-48B9-B8D4-430D704A1C7FQ36064337-E57C6068-1A85-4B72-AEDA-83271CED6A62Q36607421-D545457A-46E8-4FBB-9913-F55798795F51Q37029502-624C2416-4AD6-45CF-A19A-E7082DAA643CQ37156221-D17F38E3-18F1-45B2-B349-92C63A9EF9DFQ37183015-E1A111F4-24D9-44F6-82CB-37D0227E823DQ37489709-59A7661C-125F-4FEC-8BAA-F671740FE256Q37556629-CE78A5BB-5250-4EFA-8691-00FB5719B2E8Q37558543-8FAE4E0F-C095-48FF-82A6-39050BF4CFA6Q37624775-BA43E956-1892-4012-9CFC-FDAAA05A2929Q37663238-E7AF3DCC-B0B6-4F51-8385-CCD411D52D37Q39478148-8A233259-5831-4A4E-8213-1094BDB0CEBCQ39755565-EB79AD7B-2346-47CC-BAFB-8450053E0DFAQ40470302-C066056C-9084-4020-AA6B-D7116828E05CQ44705813-7EEA0053-20D6-4D0E-BDBF-02AB4BD26070
P2860
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
@ast
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
@en
type
label
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
@ast
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
@en
prefLabel
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
@ast
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
@en
P2093
P356
P1476
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.
@en
P2093
Henriques Normark B
Ortqvist A
Tuomanen E
P304
P356
10.1086/318697
P407
P577
2001-02-09T00:00:00Z